Antitumor cytostatic doxorubicin in liposomal form does not have a damaging effect on mitochondria
- 作者: Nikitina E.R1, Korotkov S.M1, Petunov S.G1, Vasileva K.A1, Mindukshev I.V1, Krivchenko A.I1
-
隶属关系:
- Sechenov Institute of evolutionary physiology and biochemistry RAS
- 期: 卷 14, 编号 3 (2019)
- 页面: 85-86
- 栏目: Articles
- ##submission.dateSubmitted##: 16.01.2023
- ##submission.datePublished##: 15.09.2019
- URL: https://genescells.ru/2313-1829/article/view/122419
- DOI: https://doi.org/10.23868/gc122419
- ID: 122419
如何引用文章
开放存取
##reader.subscriptionAccessGranted##
详细
全文:
作者简介
E. Nikitina
Sechenov Institute of evolutionary physiology and biochemistry RAS
Email: elena.nikitina@bk.ru
St. Petersburg, Russia
S. Korotkov
Sechenov Institute of evolutionary physiology and biochemistry RASSt. Petersburg, Russia
S. Petunov
Sechenov Institute of evolutionary physiology and biochemistry RASSt. Petersburg, Russia
K. Vasileva
Sechenov Institute of evolutionary physiology and biochemistry RASSt. Petersburg, Russia
I. Mindukshev
Sechenov Institute of evolutionary physiology and biochemistry RASSt. Petersburg, Russia
A. Krivchenko
Sechenov Institute of evolutionary physiology and biochemistry RASSt. Petersburg, Russia
参考
- Forrancs V.J. Overview of cardiac pathology in relation to anthracydine cardiac toxicity. Canc. Treat. Rep. 1978; 62: 955-61.
- Olson R.D., Mushlin P.S., Brenner D.E. et al. Doxorubicin cardio-toxicity may be caused by its metabolite, doxorubicinol. PNAS USA 1988; 85(10): 3585-9.
- Harrington K.L., Lewanski C.R., Stewart S.W. Liposomes as vehicles for targeted therapy of cancer. Part 2: Clinical development. Clin. Oncol. 2000; 12: 16-24.
补充文件
